Lung cancer incidence and mortality with extended follow-up in the National LungScreening Trial

Breathe (Sheff). 2020 Mar;16(1):190322. doi: 10.1183/20734735.0322-2019.

Abstract

The extended follow-up of the NLST represents a timely and important update to the NLST data, alongside full results of the NELSON and the LUSI trials, as Europe begins to set out a vision for lung cancer screening. http://bit.ly/2MYXedI.